In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells
Recruiting now · Not applicable
Conditions studied: Healthy
In brief
This pilot study will first establish the feasibility of an in vivo methodology of assessing the utilization of glutamine into the TCA cycle of normal bone marrow plasma cells from healthy subjects while comparing it to an ex vivo approach
Key facts
- Study ID
- NCT03384108
- Run by
- Mayo Clinic
- People needed
- 20
- Starts
- 2017-09-01
- Expected to finish
- 2028-01-01
- Last updated by the study team
- 2026-02-25
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Ages 18-60
- Able to provide written consent
You may not qualify if…
- Renal Failure
- Pregnancy
- Active steroid use
- Active liver Disease
- Anemia (Hemoglobin < 12.5 g/dL in men and < 11.5 g/dL in women)
- H/O alcohol use (average > 2 drinks per day)
- BMI > 30
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.